Form D · Biotechnology
ENCOMPASS TECHNOLOGIES, INC.
Carson City, NV · CIK 0001816168
Offering snapshot reported May 19, 2025 · SEC filing
- Reported sold
- $40.3M Offering amount: $60.3M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 19, 2025 | Initial | $40,251,391 | No comparison | 5 | SEC filing |
| Nov 20, 2023 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Aug 8, 2022 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Jun 25, 2020 | Initial | $4,000,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-546466
Source: Form D, filed May 19, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Francis Duhay | Director |
| Bruce Feuchter | Executive |
| Steven Gex | Director |
| Christopher Martin | Director |
| J.Avi Roop | Director |
| J. Avi Roop | Director |
| William Starling | Director |
| William N. Starling, Jr. | Director |
| Francis Suhay | Director |
| George Wallace | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2730 N. Deer Run Rd
Carson City, NV, 89701
Carson City, NV, 89701